Members of FDA panel call for withdrawal of Meridia diet drug

With half the panel voting for removal, it's unclear what action the FDA will take. A study found that people on Meridia have a 16% higher risk of a stroke, heart attack or other cardiac problems.In a rebuke of the Abbott Laboratories diet drug Meridia, eight of 16 members of a Food and Drug Administration advisory panel said Wednesday that the drug should be withdrawn from the U.S. market.

Read the whole article on LA Times - Science

More from LA Times - Science